Literature DB >> 8682490

Pathobiology of hepatic stellate cells.

J Mathew1, A Geerts, A D Burt.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8682490

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN： 0172-6390


× No keyword cloud information.
  7 in total

1.  A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue.

Authors:  Lisa Riccalton-Banks; Rena Bhandari; Jeffrey Fry; Kevin M Shakesheff
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

2.  All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially.

Authors:  K Hellemans; I Grinko; K Rombouts; D Schuppan; A Geerts
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells.

Authors:  J G Bode; T Peters-Regehr; A M Gressner; D Häussinger
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

4.  Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats.

Authors:  Hui Wang; Zili Dan; Haiyan Jiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

Review 5.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

6.  Reduction in SNAP-23 Alters Microfilament Organization in Myofibrobastic Hepatic Stellate Cells.

Authors:  Haleigh B Eubanks; Elise G Lavoie; Jessica Goree; Jeffrey A Kamykowski; Neriman Gokden; Michel Fausther; Jonathan A Dranoff
Journal:  Gene Expr       Date:  2019-11-22

7.  Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of hepatic stellate cells during activation.

Authors:  Nicole Testerink; Mokrish Ajat; Martin Houweling; Jos F Brouwers; Vishnu V Pully; Henk-Jan van Manen; Cees Otto; J Bernd Helms; Arie B Vaandrager
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.